ARGENX SE is 16.3x more valuable than Denali Therapeutics Inc. by market capitalization ($53.35 B vs $3.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DNLI | ARGX |
|---|---|---|
| Market cap | $3.27 B | $53.35 B |
| US-listed rank | #1734 | #306 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$512.54M | - |
| SEC filings | 763 | 272 |
ARGENX SE is 16.3x more valuable than Denali Therapeutics Inc. by market capitalization ($53.35 B vs $3.27 B).
Full pages: Denali Therapeutics Inc. and ARGENX SE, or browse the full rankings.